Winton Group Ltd

SEC CIK: 0001612063
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

CCCC holding history

C4 Therapeutics, Inc. in every 13F filed by Winton Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CCCC overview All 13F holders of CCCC Full Q2 2026 holdings

Shares (Q2 2026): 11,100
Value: $51.8K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of CCCC by Winton Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	11,100	$51.8K	<0.1%	−13,600−55.1%	Reduced	Holders
Q1 2026	24,700	$65.0K	<0.1%	+24,700	New	Holders